The pharmaceutical manufacturer is expanding its use of I-many technology including the Enterprise Contract Management (ECMF) 4.0 platform, which according to the company develops, deploys and manages applications and connectivity to other applications and environments.

The platform forms part of I-many’s ContractSphere suite of applications, which provides companies with access to integrated contract lifecycle components designed specifically for Health and Life Sciences companies.

According to I-many, its software will offer benefits including a lower total cost of ownership, advanced security model, built-in web-service based integration and platform independence.

This innovative platform will revolutionize how life sciences companies like Teva manage end-to-end contract processes and regulatory requirements across all contract types in their enterprise, said Leigh Powell, president of I-many.